Early discontinuation of long-acting reversible contraceptives at four government hospitals, Addis Ababa, Ethiopia.
Early Discontinuation
Family planning
Long-acting reversible contraception
Journal
Contraception and reproductive medicine
ISSN: 2055-7426
Titre abrégé: Contracept Reprod Med
Pays: England
ID NLM: 101703414
Informations de publication
Date de publication:
21 Jul 2023
21 Jul 2023
Historique:
received:
13
01
2023
accepted:
12
07
2023
medline:
22
7
2023
pubmed:
22
7
2023
entrez:
21
7
2023
Statut:
epublish
Résumé
Given high unmet need for contraception in Ethiopia, this study aimed to determine prevalence and factors associated with early discontinuation of long-acting reversible contraceptives (LARC). This institution-based cross-sectional study was conducted with 389 participants using exit interviews with clients presenting for removal of LARC at the family planning clinic of four government hospitals in Addis Ababa. SPSS version 26 was used for analysis. Descriptive statistics, bivariate, and multivariate logistic regression were computed. Among the 389 clients, 236 (60.7%) discontinued early. In multivariate regression, lack of pre-insertion counseling on side effects (AOR = 3.5, p = 0. 000; 95% C.I = 1.8-6.8), presence of side effects (AOR = 1.9, p = 0. 017; 95% C.I = 1. 1- 3.4), history of abortion (AOR = 3.5, p = 0. 001; 95% C.I = 1. 6- 7.4); and no prior contraception use (AOR = 2.9, p = 0. 000; 95% C.I = 1. 6- 5.3) were positively associated with early discontinuation. Whereas insertion outside of Saint Paul's Hospital Millennium Medical College (AOR = 0.4, p = 0. 000; 95% C.I = 0. 2- 0.6), and influence on choice of contraceptives by others (AOR = 0.2, p = 0. 000; 95% C.I = 0. 2- 0.4) were negatively associated with early discontinuation. Early discontinuation of LARC was high among study participants. Counseling about possible side effects and giving women the opportunity to decide their own choice of contraception might help in reducing early discontinuation.
Identifiants
pubmed: 37480045
doi: 10.1186/s40834-023-00238-8
pii: 10.1186/s40834-023-00238-8
pmc: PMC10360256
doi:
Types de publication
Journal Article
Langues
eng
Pagination
38Informations de copyright
© 2023. The Author(s).
Références
Contraception. 2006 Oct;74(4):287-9
pubmed: 16982226
BMC Res Notes. 2019 Jan 7;12(1):8
pubmed: 30616681
Biomed Res Int. 2021 Aug 06;2021:6647660
pubmed: 34395623
PLoS One. 2015 May 22;10(5):e0126759
pubmed: 26001079
Afr J Reprod Health. 2020 Jun;24(2):48-63
pubmed: 34077091
SAGE Open Med. 2022 Mar 29;10:20503121221088102
pubmed: 35371479
BMC Res Notes. 2019 Jul 17;12(1):430
pubmed: 31315656
AJOG Glob Rep. 2023 May 08;3(2):100216
pubmed: 37324808
BMC Womens Health. 2018 Nov 20;18(1):189
pubmed: 30453931
Arch Public Health. 2020 Oct 16;78:102
pubmed: 33088503
PLoS One. 2022 Aug 18;17(8):e0272701
pubmed: 35980895
Arch Public Health. 2020 Jul 01;78:36
pubmed: 32626577
BMC Womens Health. 2014 Sep 12;14:109
pubmed: 25216640
Open Access J Contracept. 2021 Feb 12;12:35-44
pubmed: 33603510
Open Access J Contracept. 2020 Aug 26;11:113-123
pubmed: 32943951